The wedding industry is anti-marriage July 4, 2024 The stress and exorbitant expense of weddings makes couple feel they are prize specimens at Crufts, rather than two human beings making solemn vows, says Phoebe Arslanagić-Little July has begun and we are in the thick of wedding season. For couples, the sting of discovering how much a photographer costs and decisions about napkin colours [...]
Fieldfisher reports double-digit revenue growth as European offices thrive July 3, 2024 Fieldfisher's annual revenue surged by 10 per cent to £352m following strong performances at its European offices, the law firm said today.
Liquidators of collapsed Arena Television launch lawsuit against British banks July 3, 2024 The liquidators of collapsed broadcaster Arena Television has launched a civil claim against Lloyds Bank and Bank of Scotland.
Election 2024: What happens when you become Prime Minister? July 3, 2024 City A.M.’s guide to a Prime Minister’s first duties once elected, including meeting the King and instructing nuclear submarines.
UK economy ‘not as bad as is often assumed’ July 3, 2024 Although the UK slipped into a shallow recession at the end of last year, the economy outperformed expectations in the first quarter of the year, growing 0.7 per cent. This made it the fastest growing economy in the G7.
City law firm HFW surpasses £250m in turnover July 3, 2024 HFW has seen its revenue increased by more than 11 per cent in the financial year ended 31 March to just over £250m mark
Election 2024: When will the next Budget be? July 3, 2024 City A.M.’s guide to when the next Budget is likely to come and what it might look like.
This government is out of ideas, out of energy, and deserves to be out of office July 3, 2024 Our verdict on the General Election: this Conservative party deserves a spell on the sidelines
Baltics Classifieds Group hikes dividend as profit rises by a third July 3, 2024 Justinas Šimkus, CEO of Baltic Classifieds Group, said "2024 marked another year of solid financial, operational and strategic execution."
GSK to pay Curevac £1.2bn for full rights to develop and commercialise mRNA vaccines July 3, 2024 GSK will assume full control of developing and manufacturing the candidate vaccines and will have worldwide rights to commercialise them.